All Articles

At the Academy of Oncology Nurse & Patient Navigators (AONN+) Fifth Annual Conference, held in Orlando, FL, in September, one nurse was recognized by her peers for her commitment to the profession. Jessica Engel, DNP, FNP-BC, AOCNP, nurse practitioner and research assistant at the Marshfield Clinic in Stevens Point, WI, was the recipient of the 2014 Oncology Nurse Excellence (ONE) Award.

The Journal of Oncology Navigation & Survivorship (JONS) recently conducted the following interview with Lillie D. Shockney, RN, BS, MAS, Administrative Director, The Johns Hopkins Breast Center; Director, Cancer Survivorship Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; and Associate Professor, Johns Hopkins University School of Medicine and School of Nursing, Baltimore, MD. Ms Shockney is also a cancer survivor and the editor-in-chief of JONS.

The following clinical trials are currently recruiting patients with small-cell lung cancer or non–small-cell lung cancer for inclusion in several investigations. Each trial description includes the NLM Identifier to use as reference with ClinicalTrials.gov.

This article describes the stigma that may be associated with a lung cancer diagnosis and its impact on body image, self-perception, and coping. Also explored are ways in which this stigma may be alleviated by the multidisciplinary oncology team, with particular emphasis on the important role oncology nurses play in the care of these patients.

“There’s a lot we don’t know about lung cancer screening,” according to Denise Aberle, MD, who spoke at the recent American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research. However, certain measures can be taken to lower false-positive and overdiagnosis rates, lessen costs, ameliorate patient suffering, and correctly identify screening cohorts, she asserted.

When I joined the faculty of the McWhorter School of Pharmacy (MSOP) at Samford University in Birmingham, Alabama, in July of 2008, I was excited to discover a corporate spirit and passion for involvement with underserved populations that were similar to that of my own.

The state of healthcare in 2014 necessitates that patients play an active role in the management of their health. But who, among Americans, has access to healthcare?

As an oncology pharmacist in an ambulatory cancer clinic, in the course of a typical week, it is not unusual for me to counsel 25 to 30 new patients on chemotherapy regimens that they are about to receive (paying particular attention to adverse events [AEs]), and to be directly involved in the monitoring and management of countless other patients who present with side effects associated with their treatments.